Qilian International Holding Group (Qilian International Holding Group) 3-Year Revenue Growth Rate : -3.10% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group 3-Year Revenue Growth Rate?

Qilian International Holding Group's Revenue per Share for the six months ended in Sep. 2023 was $0.48.

During the past 12 months, Qilian International Holding Group's average Revenue per Share Growth Rate was -28.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Qilian International Holding Group was 30.50% per year. The lowest was -3.10% per year. And the median was 8.25% per year.

Competitive Comparison of Qilian International Holding Group's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qilian International Holding Group's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's 3-Year Revenue Growth Rate falls into.

Qilian International Holding Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Qilian International Holding Group (NAS:QLI) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Qilian International Holding Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.